Risk Factors and Impact of .BETA.-D Glucan on Invasive Fungal Infection for the Living Donor Liver Transplant Recipients
Authors:
- 1 January 2006
- journal article
- research article
- Published by Tohoku University Medical Press in The Tohoku Journal of Experimental Medicine
- Vol. 209 (3) , 207-215
Abstract
Invasive fungal infection is a fatal complication in liver transplantation and it is very difficult to diagnose at the early stage. The aim of this study was to review our experience with invasive fungal infections in living donor liver transplantation (LDLT) and to analyze the risk factors and the impact of beta-D glucan. From 1991 to 2005, 96 LDLTs were performed in our institution and we measured the serum level of beta-D glucan in order to clarify the diagnosis. Invasive fungal infection was diagnosed based on clinical symptoms, culture, radiological evidence and beta-D glucan. Active fungal infection was treated with fluconazole, amphotericin B, flucytosine and micafungin. Risk factors both pre- and post- LDLT were analyzed. Candida albicans was the most frequently isolated species (70%). The risk factors identified by univariate analysis include the following four conditions: acute blood purification (plasma exchange with or without continuous hemodiafiltration), hepatic vein complications, renal failure and respiratory failure. By logistic regression analysis, hepatic vein complications and respiratory failure were identified as independent risk factors. The risk factors for invasive fungal infection of LDLT in Japan have not been well analyzed and this report will provide valuable information for the prevention of the fungal infection.Keywords
This publication has 24 references indexed in Scilit:
- Risk factors for fungal infection in paediatric liver transplant recipientsPediatric Transplantation, 2005
- Gastrointestinal infections in solid organ transplant recipientsCurrent Opinion in Organ Transplantation, 2004
- -D-Glucan as a Diagnostic Adjunct for Invasive Fungal Infections: Validation, Cutoff Development, and Performance in Patients with Acute Myelogenous Leukemia and Myelodysplastic SyndromeClinical Infectious Diseases, 2004
- TRENDS IN INVASIVE FUNGAL INFECTIONS IN LIVER TRANSPLANT RECIPIENTSTransplantation, 2002
- Fungal infections in the organ transplant recipientCurrent Opinion in Organ Transplantation, 2001
- Prevention of Fungal and Hepatitis Virus Infections in Liver TransplantationClinical Infectious Diseases, 2001
- Candida infection in pediatric liver transplant recipientsLiver Transplantation and Surgery, 1999
- Invasive Fungal Infections in Liver Transplant Recipients Receiving Tacrolimus as the Primary Immunosuppressive AgentClinical Infectious Diseases, 1997
- RISK FACTORS OF INVASIVE CANDIDA AND NON-CANDIDA FUNGAL INFECTIONS AFTER LIVER TRANSPLANTATION1Transplantation, 1996
- Factors Associated with the Development of Candidemia and Candidemia-Related Death Among Liver Transplant RecipientsAnnals of Surgery, 1996